OSENI Comprimé

Country: Կանադա

language: ֆրանսերեն

source: Health Canada

active_ingredient:

Alogliptine (Benzoate d'alogliptine); Pioglitazone (Chlorhydrate de pioglitazone)

MAH:

TAKEDA CANADA INC

ATC_code:

A10BD09

INN:

PIOGLITAZONE AND ALOGLIPTIN

dosage:

12.5MG; 15MG

pharmaceutical_form:

Comprimé

composition:

Alogliptine (Benzoate d'alogliptine) 12.5MG; Pioglitazone (Chlorhydrate de pioglitazone) 15MG

administration_route:

Orale

units_in_package:

30

prescription_type:

Prescription

therapeutic_area:

DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS

leaflet_short:

Numéro de groupe d'ingrédients actifs (GIA) :0255250001; AHFS:

authorization_status:

ANNULÉ AVANT COMMERCIALISATION

authorization_date:

2018-01-29